Recent Quotes (30 days)

You have no recent quotes
chg | %

Microbix Biosystems Inc  

(Public, TSE:MBX)   Watch this stock  
Find more results for MBX
0.285
+0.005 (1.79%)
Delayed:   11:21AM EST
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.28 - 0.28
52 week 0.18 - 0.35
Open 0.28
Vol / Avg. 100,500.00/81,726.00
Mkt cap 25.51M
P/E 32.24
Div/yield     -
EPS 0.01
Shares 84.70M
Beta -1.11
Inst. own     -
Feb 14, 2017
Q1 2017 Microbix Biosystems Inc Earnings Release (Estimated) Add to calendar
Dec 23, 2016
Q4 2016 Microbix Biosystems Inc Earnings Release
  

Key stats and ratios

Q3 (Sep '16) 2016
Net profit margin 24.86% 7.86%
Operating margin 16.02% 1.56%
EBITD margin - 12.28%
Return on average assets 13.75% 3.07%
Return on average equity 23.36% 5.17%
Employees 20 -
CDP Score - -

Address

265 Watline Ave
MISSISSAUGA, ON L4Z 1P3
Canada
+1-905-3618910 (Phone)
+1-905-3618911 (Fax)

Website links

Description

Microbix Biosystems Inc. is a life science company and manufacturer of viral and bacterial antigens and reagents for the diagnostics industry. The Company develops biological products and technologies. The Company operates in two segments: the development, manufacturing and distribution of cell-based products and technology, and the provision of facility, technical and production personnel for contract research and development. The Company's Virology Products (Virology) business manufactures and sells cell culture-based biological products. The Company's pipeline of technologies and products include Kinlytic, which is a thrombolytic drug with various applications, including the treatment of life-threatening blood clots, and LumiSort, which is a semen sexing technology for the livestock industries. It operates in three geographical areas, including North America, Europe and in other foreign countries. It owns and operates a Virology manufacturing facility at Mississauga, Ontario.

Officers and directors

William J. Gastle Executive Chairman of the Board
Vaughn C. Embro-Pantalony President, Chief Executive Officer, Director
Jim Currie Chief Financial Officer
Age: 58
Peter M. Blecher Independent Director
Mark A. Cochran Independent Director
Cameron L Groome Independent Director
Martin A. Marino Independent Director
Joseph D. Renner Independent Director